- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT07649044
Promoting Smoking Cessation in the Community Via "Quit to Win" Contest 2026: Engagement-Focused GenAI-based Chatbot for Real-Time Smoking Cessation Support (QTW2026)
Building Capacity and Promoting Smoking Cessation in the Community Via "Quit to Win" Contest 2026: Real-time Smoking Cessation Instant Messaging Support Using a Engagement-Focused Large Language Model (LLM)-Based Chatbot
The goal of this trial is to learn if chatbot-based instant messaging works to help smoking cessation in general adult smokers. It will also learn about the experience, attitude, and perception of using an LLM-based chatbot. The main questions it aims to answer are:
- Will an engagement-focused LLM-based chatbot smoking cessation intervention have a non-inferior validated abstinence rate than the control group?
- Will an LLM-based chatbot smoking cessation intervention have a non-inferior self-reported abstinence rate, smoking reduction rate, and smoking cessation services use rate than the control group?
Researchers will compare an LLM-based chatbot smoking-cessation intervention to a human-led instant messaging support group (brief advice based on AWARD and personalised active referral) to determine whether chatbot-based instant messaging support promotes smoking cessation.
Participants in the intervention group will receive:
- AWARD advice
- Personalised active referral
- 12 weeks of chatbot-based instant messaging support (via WhatsApp)
Studieoversigt
Status
Betingelser
Intervention / Behandling
- Adfærdsmæssigt: Påmindelsesbeskeder
- Adfærdsmæssigt: AWARD advice
- Adfærdsmæssigt: Brief leaflet on health warning and smoking cessation
- Adfærdsmæssigt: Referral card
- Adfærdsmæssigt: Self-help smoking cessation booklet
- Adfærdsmæssigt: Personalized active referral
- Adfærdsmæssigt: 12 weeks of chatbot-based instant messaging support
- Adfærdsmæssigt: 12 weeks of human-led instant messaging support
Detaljeret beskrivelse
Undersøgelsestype
Tilmelding (Anslået)
Fase
- Ikke anvendelig
Kontakter og lokationer
Studiekontakt
- Navn: Man Ping Wang, PhD
- Telefonnummer: +852 3917 6636
- E-mail: mpwang@hku.hk
Undersøgelse Kontakt Backup
- Navn: Yilan Wu
- Telefonnummer: +852 56497578
- E-mail: visspalan@connect.hku.hk
Studiesteder
-
-
Hong Kong
-
Hong Kong, Hong Kong, Hong Kong, 999077
- Hong Kong Council on Smoking and Health (COSH)
-
Kontakt:
- Man Ping Wang, PhD
- Telefonnummer: +852 3917 6636
- E-mail: mpwang@hku.hk
-
Underforsker:
- Shengzhi Zhao, PhD
-
Underforsker:
- Xiaoyun Xie, MPH
-
Underforsker:
- Mengyao Li, Mphil
-
Kontakt:
- Yilan Wu
- Telefonnummer: +852 56497578
- E-mail: visspalan@connect.hku.hk
-
Ledende efterforsker:
- Man Ping Wang
-
Underforsker:
- Ziqiu Guo, PhD
-
Underforsker:
- Yilan Wu, MGH
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
- Voksen
- Ældre voksen
Tager imod sunde frivillige
Beskrivelse
Inclusion Criteria:
- Hong Kong residents aged 18 years or above
- Smoke at least one cigarette (including heated tobacco products) per day or use an e-cigarette daily in the preceding 3 months
- Able to communicate in Cantonese (including reading and writing Chinese)
- Saliva cotinine level ≥30 ng/mL
- Intention to quit or reduce smoking
- Have WhatsApp installed
- Able to use WhatsApp for communication
Exclusion Criteria:
Currently participating in other smoking cessation programmes or using any smoking cessation drug
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Sundhedstjenesteforskning
- Tildeling: Randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Enkelt
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
|---|---|
|
Eksperimentel: Interventionsgruppe
|
WhatsApp-meddelelser om opfølgningsundersøgelser.
A brief (30-60 seconds) face-to-face or remote smoking cessation advice delivered using the validated AWARD model: Ask about smoking history; Warn about high health risks (accompanied by a health warning leaflet); Advise quitting as soon as possible and setting a quit date (to qualify for contest prizes); Refer to smoking cessation services using a referral card; Do it again - repeat the intervention at each follow-up, encouraging re-quitting after relapse or relapse prevention after success.
A two-sided, colour-printed A4 leaflet covering: (1) absolute risk of death from smoking; (2) full list of diseases caused by active and second-hand smoking; (3) ten pictorial warnings of health consequences on one page for maximum impact; (4) benefits of smoking cessation; and (5) simple encouraging messages to quit.
A three-folded card containing brief information and highlights of existing smoking cessation services in Hong Kong, contact methods, motivational messages, and strong supporting slogans.
A generic booklet provided covering: benefits of quitting, smoking-related diseases, methods to quit, how to handle withdrawal symptoms, a quitting declaration, and other practical tips.
Smokers will be introduced to various SC services in Hong Kong (via the referral card) and motivated to use them.
Well-trained SC ambassadors will assist smokers in choosing their favourite or most convenient type of service.
Research staff will assist participants in booking or re-booking the SC services at the 1- and 2-month follow-ups (after very brief questionnaire surveys).
Participants' contact information will be forwarded to SC service providers within 7 days, and providers are expected to contact participants within 1-2 weeks.
Research staff will also monitor participants' use of SC services at each follow-up (1-, 2-, 3-, and 6-month) and assist participants in booking or rebooking appointments if necessary at the 1- and 2-month follow-ups.
We shall liaise with the existing service providers and seek their assistance in supporting our smokers in a timely manner.
Participants in the intervention group will receive 12 weeks of instant messaging support delivered by an LLM-based chatbot (GPT-4o or newer) on WhatsApp, supporting text and audio input.
Using prompt engineering, agent techniques, and Retrieval-Augmented Generation, the chatbot delivers theory-based 5As/5Rs-structured interventions alongside freeform, on-demand support, with engagement features including personalisation, proactive check-ins, and interactive Quick Commands.
|
|
Aktiv komparator: Kontrolgruppe
|
WhatsApp-meddelelser om opfølgningsundersøgelser.
A brief (30-60 seconds) face-to-face or remote smoking cessation advice delivered using the validated AWARD model: Ask about smoking history; Warn about high health risks (accompanied by a health warning leaflet); Advise quitting as soon as possible and setting a quit date (to qualify for contest prizes); Refer to smoking cessation services using a referral card; Do it again - repeat the intervention at each follow-up, encouraging re-quitting after relapse or relapse prevention after success.
A two-sided, colour-printed A4 leaflet covering: (1) absolute risk of death from smoking; (2) full list of diseases caused by active and second-hand smoking; (3) ten pictorial warnings of health consequences on one page for maximum impact; (4) benefits of smoking cessation; and (5) simple encouraging messages to quit.
A three-folded card containing brief information and highlights of existing smoking cessation services in Hong Kong, contact methods, motivational messages, and strong supporting slogans.
A generic booklet provided covering: benefits of quitting, smoking-related diseases, methods to quit, how to handle withdrawal symptoms, a quitting declaration, and other practical tips.
Smokers will be introduced to various SC services in Hong Kong (via the referral card) and motivated to use them.
Well-trained SC ambassadors will assist smokers in choosing their favourite or most convenient type of service.
Research staff will assist participants in booking or re-booking the SC services at the 1- and 2-month follow-ups (after very brief questionnaire surveys).
Participants' contact information will be forwarded to SC service providers within 7 days, and providers are expected to contact participants within 1-2 weeks.
Research staff will also monitor participants' use of SC services at each follow-up (1-, 2-, 3-, and 6-month) and assist participants in booking or rebooking appointments if necessary at the 1- and 2-month follow-ups.
We shall liaise with the existing service providers and seek their assistance in supporting our smokers in a timely manner.
Participants in the control group will receive 12 weeks of instant messaging support delivered by a trained human counsellor via WhatsApp.
Using the same theoretical frameworks as the chatbot intervention, the counsellor will provide real-time behavioural and psychosocial support grounded in the 5As/5Rs models, Motivational Interviewing (MI), and evidence-based Behaviour Change Techniques (BCTs).
The support will be personalised according to each participant's sociodemographic characteristics, smoking patterns, quit intentions, and plans.
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Biokemisk valideret abstinens
Tidsramme: 6 måneders opfølgning
|
Defineret som udåndet CO-niveau <4ppm og spyt-kotinin-niveau ≤30 ng/ml
|
6 måneders opfølgning
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Biokemisk valideret abstinens
Tidsramme: 3 måneders opfølgning
|
Defineret som udåndet CO-niveau <4ppm og spyt-kotinin-niveau ≤30 ng/ml
|
3 måneders opfølgning
|
|
Selvrapporteret 7-dages pointudbredelse afholdenhed
Tidsramme: 3- og 6-måneders opfølgning
|
Rygere, der ikke ryger engang en puff i de 7 dage forud for opfølgningen
|
3- og 6-måneders opfølgning
|
|
Selvrapporteret reduktion
Tidsramme: 1-, 2-, 3- og 6-måneders opfølgning
|
Defineret ved mindst 50% reduktion i baseline dagligt antal cigaretter
|
1-, 2-, 3- og 6-måneders opfølgning
|
|
Selvrapporteret brug af rygestop-service
Tidsramme: 1-, 2-, 3- og 6-måneders opfølgning
|
Brug af rygestop-service ved 1-, 2-, 3- og 6-måneders opfølgning.
|
1-, 2-, 3- og 6-måneders opfølgning
|
|
Prolonged abstinence
Tidsramme: 3-month and 6-month follow-ups
|
Abstinence from smoking for 3 consecutive months at 3-month follow-up, or for 6 consecutive months at 6-month follow-up
|
3-month and 6-month follow-ups
|
|
Quit attempt
Tidsramme: 1-, 2-, 3-, and 6-month follow-ups
|
Abstinence for at least 24 hours
|
1-, 2-, 3-, and 6-month follow-ups
|
|
Post-cessation weight change
Tidsramme: 6-month follow-up
|
Self-reported change in body weight (in kilograms) from baseline to follow-up
|
6-month follow-up
|
|
Self-reported mental health conditions
Tidsramme: Baseline and 6-month follow-up
|
Patient Health Questionnaire-4 (PHQ-4)
|
Baseline and 6-month follow-up
|
|
Self-reported smoking-related health conditions
Tidsramme: Baseline and 6-month follow-up
|
Answer "Yes" to experiencing any smoking-related health condition during smoking cessation or reduction
|
Baseline and 6-month follow-up
|
|
Chatbot user experience
Tidsramme: 3-month follow-up
|
Chatbot Usability Scale
|
3-month follow-up
|
Samarbejdspartnere og efterforskere
Sponsor
Efterforskere
- Ledende efterforsker: Man Ping Wang, The University of Hong Kong
Datoer for undersøgelser
Studer store datoer
Studiestart (Anslået)
Primær færdiggørelse (Anslået)
Studieafslutning (Anslået)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Faktiske)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- QTW2026
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Studerer et amerikansk FDA-reguleret enhedsprodukt
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med Påmindelsesbeskeder
-
Elisabeth-TweeSteden ZiekenhuisErasmus Medical Center; Medical Center Haaglanden; ZonMw: The Netherlands... og andre samarbejdspartnereUkendtKognitiv svækkelse | Hjernetumor, primærHolland
-
YuanYuan MaAfsluttet
-
Universiti Putra MalaysiaUnited NationsIkke rekrutterer endnuSarkopeni | Kognitiv skrøbelighed | Ernæringsmæssige interventionerMalaysia
-
University of California, San FranciscoUniversity of California, Berkeley; Tilburg UniversityRekrutteringGliom af lav kvalitetForenede Stater